Tag: Lupin

Lupin inks pact to acquire two inhalation brands from Sunovion for $75 million

NEW DELHI: Drug maker Lupin on Thursday said it will acquire two inhalation brands from Sunovion Pharmaceuticals Inc for USD 75 million (around Rs 622 crore). The drug firm has inked a pact with US-based Sunovion to acquire Brovana (arformoterol tartrate) inhalation solution and Xopenex HFA (levalbuterol tartrate) inhalation aerosol. The Mumbai-based firm expects the […]

US FDA grants orphan drug status to mexiletine hydrochloride: Lupin

NEW DELHI: Pharma major Lupin on Monday said the US health regulator has granted orphan drug designation (ODD) to mexiletine hydrochloride for the treatment of myotonic disorders. The Mumbai-based company’s drug NaMuscula (mexiletine hydrochloride) is the first and only licensed product to treat myotonia in adults with non-dystrophic myotonic (NDM) disorders. The company has already […]

Back To Top